Rekor Systems Offers Policymakers a Privacy-Protected and Responsible Path Forward for the Use of Automated License Plate Recognition

Rekor Systems Offers Policymakers a Privacy-Protected and Responsible Path Forward for the Use of Automated License Plate Recognition GlobeNewswire November 19, 2025 COLUMBIA, Md., Nov. 19, 2025 (GLOBE NEWSWIRE) — Rekor Systems, Inc. (NASDAQ: REKR) (“Rekor” or the “Company”), a leader in developing and implementing state-of-the-art roadway intelligence technology, today announced that it has developed […]

Brookfield Launches $100 Billion AI Infrastructure Program

Brookfield Launches $100 Billion AI Infrastructure Program GlobeNewswire November 19, 2025 $100 Billion Investment Program to be Deployed Across the Full AI Value Chain NVIDIA and KIA Will Each Join the Fund as Investors and Founding Partners NEW YORK, Nov. 19, 2025 (GLOBE NEWSWIRE) — Brookfield today announced the launch of a $100 billion global

Juno Announces $18 Million Fully Allocated Non-Brokered Private Placement with Participation from Northfield Capital and Strategic Investor

Juno Announces $18 Million Fully Allocated Non-Brokered Private Placement with Participation from Northfield Capital and Strategic Investor GlobeNewswire November 19, 2025 Not for distribution to U.S. Newswire Services or for release, publication, distribution or dissemination directly, or indirectly, in whole or in part, in or into the United States TORONTO, Nov. 19, 2025 (GLOBE NEWSWIRE)

White Gold Corp. Welcomes Federal Nation-Building Investments and Support for Resource Development in Yukon

White Gold Corp. Welcomes Federal Nation-Building Investments and Support for Resource Development in Yukon GlobeNewswire November 19, 2025 TORONTO, Nov. 19, 2025 (GLOBE NEWSWIRE) — White Gold Corp. (TSX.V: WGO, OTCQX: WHGOF, FRA: 29W) (the “Company”) welcomes the Government of Canada's announcement of the second tranche of nation-building projects under Budget 2025: Canada Strong. This

Mobix Labs Expands Into High-Growth AI Infrastructure With Strategic Investment in TalkingHeads Wireless

Mobix Labs Expands Into High-Growth AI Infrastructure With Strategic Investment in TalkingHeads Wireless GlobeNewswire November 19, 2025 IRVINE, Calif., Nov. 19, 2025 (GLOBE NEWSWIRE) — Mobix Labs, Inc. (Nasdaq: MOBX), a high-performance fabless semiconductor and connectivity company, today announced it has taken a strategic minority stake in TalkingHeads Wireless (THW), an AI-powered wireless infrastructure innovator

Aya Gold & Silver Unlocks Near-Term Value and Advances Environmental Remediation with Sale of Precious Metals from Legacy Boumadine Stockpile

Aya Gold & Silver Unlocks Near-Term Value and Advances Environmental Remediation with Sale of Precious Metals from Legacy Boumadine Stockpile GlobeNewswire November 19, 2025 MONTREAL, Nov. 19, 2025 (GLOBE NEWSWIRE) — Aya Gold & Silver Inc. (TSX: AYA; OTCQX: AYASF) (“Aya” or the “Corporation”) is pleased to announce the start of commercial production from a

Troilus Upsizes Debt Financing Mandate to US$1 Billion

Troilus Upsizes Debt Financing Mandate to US$1 Billion Increase reflects strong market conditions, enhanced project economics, and lender confidence GlobeNewswire November 19, 2025 MONTREAL, Nov. 19, 2025 (GLOBE NEWSWIRE) — Troilus Gold Corp. (TSX: TLG; OTCQX: CHXMF; FRA: CM5R) (“Troilus” or the “Company”) is pleased to announce that it has increased its previously announced debt

SCYNEXIS Completes Transfer of BREXAFEMME(R) New Drug Application to GSK

SCYNEXIS Completes Transfer of BREXAFEMME(R) New Drug Application to GSK GlobeNewswire November 19, 2025 GSK remains committed to the relaunch of BREXAFEMME, and following its relaunch, SCYNEXIS stands to receive up to $145.5 million in annual net sales milestones as well as royalties, net of payments to Merck, in the low to mid single digit

EyePoint Announces Positive Recommendation from Independent Data Safety Monitoring Committee for Pivotal Phase 3 Trials for DURAVYU(TM) in Wet Age-Related Macular Degeneration

EyePoint Announces Positive Recommendation from Independent Data Safety Monitoring Committee for Pivotal Phase 3 Trials for DURAVYU(TM) in Wet Age-Related Macular Degeneration GlobeNewswire November 19, 2025 – No changes in protocol recommended for LUGANO and LUCIA clinical trials – – Masked safety data continues to show no safety signals, consistent with previous clinical trials for

Atea Pharmaceuticals to Present at the 8th Annual Evercore Healthcare Conference

Atea Pharmaceuticals to Present at the 8th Annual Evercore Healthcare Conference GlobeNewswire November 19, 2025 BOSTON, Nov. 19, 2025 (GLOBE NEWSWIRE) — Atea Pharmaceuticals, Inc. (Nasdaq: AVIR) (Atea or Company), a clinical-stage biopharmaceutical company engaged in the discovery and development of oral antiviral therapeutics for serious viral diseases, today announced that Jean-Pierre Sommadossi, PhD, Chief

Scroll to Top